Genetic Predisposition Clinical Trial
Official title:
Diagnostic Research in Patients With Rare Diseases - Solving the Unsolved Rare Diseases
The DiRiP study will enroll patients (n = 3500) with unclear rare diseases and suspected genetic reasons. In group 1 (n = 500) subjects are clinically characterized in the context of outpatient/ inpatient standard care at the UKT or cooperating location, NGS analyzes and other omics analyzes (transcriptomics, proteomics, metabolomics), functional cell biology studies will be performed. In group 2 diagnostics is already performed. The DiRiP-study fully integrates with the newly formed European Reference Networks (ERNs) for rare diseases, and in particular the ERN-RND, -EURO-NMD, -ITHACA, and -GENTURIS.
In the DiRiP-RD study (monocentric, prospective, open-label diagnostic study), patients with genetically unexplained diseases will be analyzed or re-analyzed from existing datasets for further omics analysis. These are evaluated with regard to the following questions: Primary: - Verification of the genetic causes of unclear genetic diseases Secondary: - Improve number of diagnoses of unclear syndromes - Further characterization of the identified gene defects - Number of patients receiving appropriate therapy after successful diagnosis. In addition, patient phenotype and genotype data can be collected using a software tool for collecting and analyzing phenotypic information of patients with genetic disorders ( PhenoTips®) software to facilitate data exchange within the UKT, with external collaborators and data transfer to the Solve-RD project. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT04746794 -
Early Detection of GEnetic Risk (EDGE)
|
N/A | |
| Completed |
NCT03792685 -
Looking for Personalized Nutrition for Obesity/Type 2 Diabetes Mellitus Prevention
|
N/A | |
| Recruiting |
NCT04970056 -
Pancreatic Cancer Early Detection Consortium
|
||
| Terminated |
NCT04119596 -
Study of the Genome, Gut Metagenome and Diet of Patients With Incident Parkinson's Disease
|
||
| Recruiting |
NCT04141462 -
EXOME Analysis Position in the Strategy of Genetic Predisposition Factors Identification in Early-onset Cancer
|
N/A | |
| Completed |
NCT02826330 -
Abnormal Fecal Microbiota in Healthy Subjects at High Risk for Crohn's Disease
|
||
| Recruiting |
NCT05929976 -
InterNatIonal CHildhood Leukemia Microbiome/MEtabolome Cohort
|
||
| Not yet recruiting |
NCT04620278 -
Genetic Investigation of Cancer Predisposition
|
||
| Active, not recruiting |
NCT02373709 -
Sequence Variations of Genes in the Estrogen Pathway and Perinatal Depression
|
||
| Not yet recruiting |
NCT06089421 -
Genetic Information Assistant in Telegenetics
|
N/A | |
| Completed |
NCT05975489 -
Genetics in the Effect of Caffeine on Fat Oxidation
|
N/A | |
| Completed |
NCT03954652 -
Whole Genome Trio Sequencing as a Standard Routine Test in Patients With Rare Diseases - "GENOME FIRST APPROACH"
|
N/A | |
| Completed |
NCT04113239 -
Study of the Genome, Gut Metagenome and Lifestyle of Patients With Incident Type 2 Diabetes Mellitus
|
||
| Enrolling by invitation |
NCT04373525 -
Prospective Evaluation on Cognitive Function and Its Associated Genetic Vulnerability in Cannabis Users
|
||
| Completed |
NCT03362099 -
Efficacy of the Use of Genetic Markers in the Choice of the Pharmacological Treatment of Smoking (GENTSMOKING)
|
Phase 4 | |
| Recruiting |
NCT05857670 -
Psyco Quality of Life and Procreation BRCA1/2
|
||
| Active, not recruiting |
NCT04774445 -
Effectiveness of MyCancerGene to Optimize Genetic Testing Outcomes
|
N/A | |
| Recruiting |
NCT05759143 -
Enhancing Information Management for Young Adults After Genetic Cancer Risk Testing
|
N/A | |
| Active, not recruiting |
NCT04920513 -
Universal- Versus Guidelines-Directed Genetic Testing for Germline Pathogenic Variants Utilizing a Multi-Gene Panel for Inherited Cancers in Non-Western Society.
|
||
| Active, not recruiting |
NCT04781205 -
Genome Driven Primary Care Clinics - an RCT
|
N/A |